☆ 4.7 Article

Saccharomyces boulardii Allows Partial Patients to Avoid Reusing Bismuth Quadruple for Helicobacter pylori Rescue Therapy: A Single-Center Randomized Controlled Study

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial

Nooshin Naghibzadeh et al.

Summary: This study investigated the effects of treatment with Saccharomyces boulardii and Lactobacillus reuteri on the eradication of Helicobacter pylori and adverse effects of the treatment. The results showed that S. boulardii could significantly reduce some adverse effects of H. pylori eradication therapy, while the effectiveness of L. reuteri was not significant.

BMC GASTROENTEROLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Treatment of Helicobacter pylori infection in the presence of penicillin allergy

Amit Kumar Dutta et al.

Summary: Treatment options for H.pylori infection in patients with penicillin allergy include first-line Bismuth-based quadruple therapy for 10-14 days, and second-line Levoflaxacin-based triple therapy for 10 days. Patients with persistent infection after 2 treatment courses should be tested for penicillin allergy, and treatment should be guided by H.pylori culture and sensitivity testing results.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review

Shailja C. Shah et al.

Summary: The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of Helicobacter pylori after initial eradication therapy failure. The review is not formal systematic, but based on literature to provide practical advice. The strength or quality of the evidence was not formally rated, instead a combination of available evidence and consensus-based expert opinion were used to develop best practice advice.

GASTROENTEROLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

An overview of traditional Chinese medicine therapy for Helicobacter pylori-related gastritis

Yuli Li et al.

Summary: This review explores the clinical efficacy of TCM formulas for HPAG, as well as the active ingredients and pharmacological mechanisms of herbs. The study also suggests potential prospects for future research in this area. The therapeutic benefits of TCM in treating HPAG have been demonstrated, and further research is recommended for the development of TCM with more specific functions.

HELICOBACTER (2021)

添加到收藏夹

Article Medicine, General & Internal

Saccharomyces boulardii Combined With Quadruple Therapy for Helicobacter pylori Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective Randomized Controlled Trial

Yuchong Zhao et al.

Summary: The combination of S. boulardii and quadruple therapy for H. pylori eradication significantly reduces the incidence and duration of diarrhea, but did not have a significant impact on the eradication rate.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications

Evariste Tshibangu-Kabamba et al.

Summary: Helicobacter pylori is a major human pathogen with increasing antibiotic resistance posing a serious threat to human health. The resistance mechanisms include single drug resistance, multidrug resistance, and heteroresistance, primarily related to mutational changes and target-mediated mechanisms. Further research is needed to explore additional biological attributes driving drug resistance in H. pylori for better treatment outcomes.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults

Ziying Yuan et al.

Summary: This study investigated the impact of H. pylori eradication and probiotics intervention on the gastric microbiota in young adults. The results showed changes in the diversity and composition of gastric microbiota after successful H. pylori eradication, with probiotics supplementation partially aiding in restoring dysbiosis. However, probiotics alone may not be necessary for H. pylori-infected young adults.

HELICOBACTER (2021)

添加到收藏夹

Article Biochemical Research Methods

Phenotypic-dependent variability and the emergence of tolerance in bacterial populations

Jose Camacho Mateu et al.

Summary: Ecological and evolutionary dynamics are now well-documented to interplay tightly, especially in microbial communities. The distribution of single-cell lag times evolves to approximately fit antibiotic-exposure time, showing right-skewed heavy tails with individuals having anomalously large lag times.

PLOS COMPUTATIONAL BIOLOGY (2021)

添加到收藏夹

Article Immunology

Fungemia and other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements

Juha Rannikko et al.

Summary: The study assessed the association between the use of S. boulardii probiotic and Saccharomyces fungemia, finding a higher odds ratio among patients using the probiotic. Additionally, the study shed light on the scale of nonblood Saccharomyces culture findings linked to use of this probiotic.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy

Soichiro Sue et al.

Summary: The study demonstrates that the 7-day VPZ-MNZ-STFX rescue therapy has a high eradication rate of H. pylori in patients with penicillin allergy, with good tolerability, particularly in terms of completing the medication course.

JGH OPEN (2021)

添加到收藏夹

Article Infectious Diseases

Fatal fulminant Clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report

Takahito Nei et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Efficacy and safety of a new rifabutin-based triple therapy with vonoprazan for refractoryHelicobacter pyloriinfection: A prospective single-arm study

Yoshihiro Hirata et al.

HELICOBACTER (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Efficacy of bismuth-based quadruple therapy for eradication ofHelicobacter pyloriinfection based on previous antibiotic exposure: A large-scale prospective, single-center clinical trial in China

Jing-Jing Zhou et al.

HELICOBACTER (2020)

添加到收藏夹

Article Infectious Diseases

Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome

Paul A. Cardenas et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections

Dorota Czerucka et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?

Nuzhat Qureshi et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)

添加到收藏夹

Article Medical Laboratory Technology

Antibiotic resistance of Helicobacter pylori to 16 antibiotics in clinical patients

Yongfu Shao et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)

添加到收藏夹

Article Medicine, General & Internal

The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial

Luyi Chen et al.

EBIOMEDICINE (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report

P. Malfertheiner et al.

GUT (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis

James K. Y. Hooi et al.

GASTROENTEROLOGY (2017)

添加到收藏夹

Article Dermatology

Seven cases of Saccharomyces fungaemia related to use of probiotics

Ujjwayini Roy et al.

MYCOSES (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Review article: the global emergence of Helicobacter pylori antibiotic resistance

I. Thung et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

Carlo A. Fallone et al.

GASTROENTEROLOGY (2016)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection

H. Szajewska et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea

H. Szajewska et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection

Jyh-Chin Yang et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

添加到收藏夹

Review Oncology

Helicobacter pylori in gastric carcinogenesis

Hyo Jun Ahn et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2015)

添加到收藏夹

Article Immunology

Saccharomyces boulardii expresses neuraminidase activity selective for α2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells

Serhan Sakarya et al.

APMIS (2014)

添加到收藏夹

Review Oncology

Helicobacter pylori-induced gastric inflammation and gastric cancer

Fei Wang et al.

CANCER LETTERS (2014)

添加到收藏夹

Article Multidisciplinary Sciences

The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis

Yini Dang et al.

PLOS ONE (2014)

添加到收藏夹

Article Infectious Diseases

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial

Jyh-Ming Liou et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment

H. Szajewska et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)

添加到收藏夹

Article Gastroenterology & Hepatology

Long-term Administration of Probiotics to Asymptomatic Pre-school Children for Either the Eradication or the Prevention of Helicobacter pylori Infection

Surasak Boonyaritichaikij et al.

HELICOBACTER (2009)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Influence of pH conditions on the viability of Saccharomyces boulardii yeast

Sandrine Graff et al.

JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY (2008)

添加到收藏夹

Article Gastroenterology & Hepatology

Helicobacter and Gastric Malignancies

Steven F. Moss et al.

HELICOBACTER (2007)

添加到收藏夹

Article Pharmacology & Pharmacy

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy

Naohito Shirai et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)

添加到收藏夹

Article Infectious Diseases

Macrolide resistance in the normal microbiota after Helicobacter pylori treatment

Hedvig Jakobsson et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)

添加到收藏夹

Article Gastroenterology & Hepatology

Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure

Jacob Yahav et al.

DIGESTIVE DISEASES AND SCIENCES (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.